1. Home
  2. MDBH vs RNXT Comparison

MDBH vs RNXT Comparison

Compare MDBH & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MDB Capital Holdings LLC common

MDBH

MDB Capital Holdings LLC common

N/A

Current Price

$3.59

Market Cap

37.7M

Sector

N/A

ML Signal

N/A

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

HOLD

Current Price

$0.90

Market Cap

37.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDBH
RNXT
Founded
1997
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.7M
37.0M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
MDBH
RNXT
Price
$3.59
$0.90
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.25
AVG Volume (30 Days)
5.0K
277.5K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.00
EPS
N/A
N/A
Revenue
N/A
$1,123,000.00
Revenue This Year
N/A
$194.66
Revenue Next Year
N/A
$279.78
P/E Ratio
$4.06
N/A
Revenue Growth
N/A
2511.63
52 Week Low
$2.75
$0.70
52 Week High
$5.50
$1.45

Technical Indicators

Market Signals
Indicator
MDBH
RNXT
Relative Strength Index (RSI) 54.05 44.29
Support Level $3.16 $0.89
Resistance Level $3.62 $1.07
Average True Range (ATR) 0.13 0.05
MACD -0.04 -0.01
Stochastic Oscillator 19.58 39.12

Price Performance

Historical Comparison
MDBH
RNXT

About MDBH MDB Capital Holdings LLC common

MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The company operates in two reportable segments: a broker dealer & intellectual property service; and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: